Clariane Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Clariane şirketinin toplam hissedar öz sermayesi €3.9B ve toplam borcu €4.3B olup, bu da borç-öz sermaye oranını 111.1% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla €14.6B ve €10.8B dir. Clariane 'in FAVÖK'ü €304.5M faiz karşılama oranı 1 dur. Şirketin €522.4M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

111.1%

Borç/özkaynak oranı

€4.29b

Borç

Faiz karşılama oranı	1x
Nakit	€522.45m
Eşitlik	€3.86b
Toplam yükümlülükler	€10.76b
Toplam varlıklar	€14.61b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 0OPS 'nin kısa vadeli varlıkları ( €1.9B ) kısa vadeli yükümlülüklerini ( €3.2B ) kapsamıyor.

Uzun Vadeli Yükümlülükler: 0OPS 'un kısa vadeli varlıkları ( €1.9B ) uzun vadeli yükümlülüklerini ( €7.6B ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 0OPS 'nin net borç/öz sermaye oranı ( 97.6% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: 0OPS 'nin borç/öz sermaye oranı son 5 yılda 111.3% seviyesinden 111.1% seviyesine düştü.

Borç Kapsamı: 0OPS 'nin borcu işletme nakit akışı ( 21.8% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 0OPS 'in borcuna ilişkin faiz ödemeleri EBIT ( 1 x kapsam) tarafından iyi karşılanmıyor.

Clariane Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Clariane SE, Annual General Meeting, May 14, 2025

Clariane SE to Report Fiscal Year 2024 Results on Feb 24, 2025

Clariane Group Announces Management Changes

First half 2024 earnings released

Clariane Se Provides Earnings Guidance for the Full Year 2024; Reiterates Earnings Guidance for the Full Year from 2023 to 2026

New major risk - Shareholder dilution

Odalys SA acquired Les Essentielles - SARL from Clariane SE (ENXTPA:CLARI).

New minor risk - Shareholder dilution

Clariane SE has filed a Follow-on Equity Offering in the amount of €237.083186 million.

Clariane SE Appoints Sylvia Metayer as Non-Executive Director

Clariane Confirms Rumor of Disposal of HAD/SSIAD Business in France

Full year 2023 earnings released

Elevation Healthcare Properties managed by Elevation Advisors signed an agreement to acquire Berkley Care Group Ltd from Clariane SE (ENXTPA:CLARI) for £207 million.

Investor sentiment improves as stock rises 20%

Investor sentiment deteriorates as stock falls 17%

Clariane SE to Report First Half, 2024 Results on Jul 30, 2024

Investor sentiment deteriorates as stock falls 19%

New minor risk - Share price stability

Clariane SE to Report Fiscal Year 2023 Results on Feb 28, 2024

Investor sentiment deteriorates as stock falls 17%

Now 20% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 15%

First half 2023 earnings released

Clariane Announces Dividend for the Financial Year 2022, Payable on July 13, 2023

Clariane Announces Dividend for the Financial Year 2022, Payable on July 13, 2023

Upcoming dividend of €0.25 per share at 3.4% yield

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 19%

Full year 2022 earnings released

Korian (ENXTPA:KORI) acquired Grupo 5 Acción y Gestión Social, S.A. from Corpfin Capital Asesores, S.A., SGEIC and others.

Korian to Report First Half, 2023 Results on Jul 27, 2023

Investor sentiment deteriorated over the past week

First half 2022 earnings released

Korian Appoints Philippe Lévêque as Director and Chairman of the Ethics, Quality and CSR Committee

Upcoming dividend of €0.35 per share

Investor sentiment deteriorated over the past week

High number of new directors

Korian Proposes Dividend

Full year 2021 earnings: Revenues in line with analyst expectations

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Icade Santé SAS completed the acquisition of 2 nursing homes in Le Teilleul and Notre-Dame-de-Sanilhac from Korian (ENXTPA:KORI) for €13 million.

Korian Provides Sales Guidance for the Year 2022

First half 2021 earnings released: EPS €0.31 (vs €0.13 in 1H 2020)

Korian (ENXTPA : KORI) acquired a 90% stake in Santa Croce s.r.l.

Korian in Exclusive Talks to Acquire Osny Psychotherapy Centre in Val d’Oise

Icade Santé SAS acquired One Post-Acute Care Facility and Two Nursing Homes from Korian (ENXTPA:KORI).

Korian (ENXTPA:KORI) completed the acquisition of ITA Mental Health from Magnum Capital Industrial Partners.

Korian Approves Dividend, Payable on July 1, 2021

Upcoming dividend of €0.30 per share

Korian Provides Revenue Guidance for the Full Year 2021 and Full Year 2022

Korian (ENXTPA:KORI) signed an agreement to acquire ITA Mental Health from Magnum Capital Industrial Partners.

Revenue beats expectations

Full year 2020 earnings released

Korian (ENXTPA:KORI) acquired unknown minority stake in Viva Son Group.

Korian Demonstrates the Relevance of its Asset Smart Strategy through a Partnership with BNP Paribas Cardif and EDF Invest

New 90-day high: €30.99

Icade SA (ENXTPA:ICAD) agreed to acquire Four Nursing Homes in France from Korian (ENXTPA:KORI) for €33.5 million.

Korian (ENXTPA:KORI) completed the acquisition of Inicea Groupe from Antin Infrastructure Partners S.A.S.

Korian Signs Development Partnership with Aedifica in the Netherlands

Korian has completed a Follow-on Equity Offering in the amount of €400.250658 million.

Korian to Report First Half, 2021 Results on Jul 29, 2021

New 90-day low: €26.46

Korian to Report Fiscal Year 2020 Results on Feb 24, 2021

New 90-day low: €26.70

Korian (ENXTPA:KORI) reached a non binding deal to acquire Inicea Groupe for €360 million.

Korian Announces Executive Changes

Korian (ENXTPA:KORI) entered into an agreement to acquire Five Facilities near Amsterdam from Ontzorgd Wonen Groep B.V.

New 90-day low: €30.48

New 90-day low - €31.59

Korian (ENXTPA:KORI) acquired Santa Marinella.

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço